We suggest that the consequences of disrupting CRMP2 expression include glucose intolerance and obesity due to the inefficient glucose uptake but excess lipid synthesis and accumulation, which eventually would lead to the development of insulin resistance and diabetic onset. This evidence concerns the gene DPYSL2 and obesity disorder.